Albany Molecular Research, Inc. (AMRI) Appoints New Director of DMPK, Further Strengthening its Integrated Discovery Biology and Chemistry Platform

ALBANY, N.Y.--(BUSINESS WIRE)--AMRI (NASDAQ: AMRI) announced today that Charles Jensen, Ph.D., has joined AMRI as director of Drug Metabolism and Pharmacokinetics (DMPK), reporting to Bruce J. Sargent, Ph.D., Senior Vice President of Drug Discovery.